Greenland Mines Ltd (GRML)
NASDAQ: GRML · Real-Time Price · USD
0.3700
+0.0400 (12.12%)
At close: Apr 1, 2026, 4:00 PM EDT
0.3841
+0.0141 (3.81%)
After-hours: Apr 1, 2026, 7:18 PM EDT
Company Description
Greenland Mines Ltd operates as a natural resources company.
It focuses on the exploration and development of Skaergaard Project in Southeast Greenland. The company is also involved in the development of KLTO-202, a cell and gene therapy for amyotrophic lateral sclerosis.
The company was formerly known as Klotho Neurosciences, Inc. and changed its name to Greenland Mines Ltd in March 2026.
Greenland Mines Ltd is based in Charlotte, North Carolina.
Greenland Mines Ltd
| Country | United States |
| Industry | Other Precious Metals & Mining |
| Sector | Materials |
| Employees | 3 |
| CEO | Joseph Sinkule |
Contact Details
Address: 1300 South Boulevard, Suite D Charlotte, North Carolina 28203 United States | |
| Phone | 833 931 6330 |
| Website | greenlandmines.com |
Stock Details
| Ticker Symbol | GRML |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US49876K1034 |
Key Executives
| Name | Position |
|---|---|
| Dr. Joseph A. Sinkule Pharm.D. | Founder, Chief Executive Officer, Chairman of the Board and Secretary |
| Jeffrey LeBlanc | Chief Financial Officer |
| Dr. Shalom Z. Hirschman M.D. | Medical Advisor and Director |
| Peter J. Moriarty | Chief Business Officer |
| Dr. Miguel Chillon Rodriguez | Chief Scientific Officer and Consultant |